Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 2.12% |
| Q3 2025 | -42.52% |
| Q2 2025 | -4.00% |
| Q1 2025 | -55.43% |
| Q4 2024 | -257.93% |
| Q3 2024 | 225.82% |
| Q2 2024 | 6.09% |
| Q1 2024 | -17.00% |
| Q4 2023 | -257.79% |
| Q3 2023 | 71.29% |
| Q2 2023 | 180.30% |
| Q1 2023 | 92.13% |
| Q4 2022 | -770.12% |
| Q3 2022 | 1.94% |
| Q2 2022 | 5.27% |
| Q1 2022 | 184.65% |
| Q4 2021 | -184.47% |
| Q3 2021 | 93.55% |
| Q2 2021 | -91.73% |
| Q1 2021 | 938.24% |
| Q4 2020 | -27.33% |
| Q3 2020 | -203.78% |
| Q2 2020 | 180.44% |
| Q1 2020 | 5.26% |
| Q4 2019 | -24.46% |
| Q3 2019 | -24.22% |
| Q2 2019 | -9.50% |
| Q1 2019 | 25.39% |
| Q4 2018 | -43.30% |
| Q3 2018 | 17.72% |
| Q2 2018 | -54.44% |
| Q1 2018 | 11.52% |
| Q4 2017 | -5.48% |
| Q3 2017 | 56.53% |
| Q2 2017 | 13.85% |
| Q1 2017 | 90.74% |
| Q4 2016 | -739.31% |
| Q3 2016 | 3.65% |
| Q2 2016 | 18.13% |
| Q1 2016 | -27.73% |